Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 11/2016

Ausgabe 11/2016

Inhaltsverzeichnis ( 13 Artikel )

29.07.2016 | Review | Ausgabe 11/2016 Open Access

Beta-glucan contamination of pharmaceutical products: How much should we accept?

Claire Barton, Kim Vigor, Robert Scott, Paul Jones, Heike Lentfer, Heather J. Bax, Debra H. Josephs, Sophia N. Karagiannis, James F. Spicer

12.08.2016 | Original Article | Ausgabe 11/2016

The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice

Claudia Lanterna, Andrea Musumeci, Laura Raccosta, Gianfranca Corna, Marta Moresco, Daniela Maggioni, Raffaella Fontana, Claudio Doglioni, Claudio Bordignon, Catia Traversari, Vincenzo Russo

26.08.2016 | Original Article | Ausgabe 11/2016

Quantification of PD-L1 and PD-1 expression on tumor and immune cells in non-small cell lung cancer (NSCLC) using non-enzymatic tissue dissociation and flow cytometry

Amanda Chargin, Rian Morgan, Uma Sundram, Keith Shults, Ellen L. Tsay, Navneet Ratti, Bruce K. Patterson

29.08.2016 | Original Article | Ausgabe 11/2016

NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells

John O. Richards, Alex J. Albers, Thomas S. Smith, Judy A. Tjoe

01.10.2016 | Erratum | Ausgabe 11/2016

Erratum to: NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells

John O. Richards, Alex J. Albers, Thomas S. Smith, Judy A. Tjoe

30.08.2016 | Original Article | Ausgabe 11/2016 Open Access

Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma

Robert A. Fenstermaker, Michael J. Ciesielski, Jingxin Qiu, Nuo Yang, Cheryl L. Frank, Kelvin P. Lee, Laszlo R. Mechtler, Ahmed Belal, Manmeet S. Ahluwalia, Alan D. Hutson

31.08.2016 | Original Article | Ausgabe 11/2016

A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas

Megan C. Duggan, Caroline Jochems, Renee N. Donahue, Jacob Richards, Volodymyr Karpa, Elizabeth Foust, Bonnie Paul, Taylor Brooks, Susheela Tridandapani, Thomas Olencki, Xueliang Pan, Gregory B. Lesinski, Jeffrey Schlom, William E. Carson III

01.09.2016 | Original Article | Ausgabe 11/2016

The role of Ly49E receptor expression on murine intraepithelial lymphocytes in intestinal cancer development and progression

Aline Van Acker, Els Louagie, Jessica Filtjens, Sylvie Taveirne, Els Van Ammel, Tessa Kerre, Dirk Elewaut, Tom Taghon, Bart Vandekerckhove, Jean Plum, Georges Leclercq

06.09.2016 | Original Article | Ausgabe 11/2016

Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes

Andreas Gloger, Danilo Ritz, Tim Fugmann, Dario Neri

07.09.2016 | Original Article | Ausgabe 11/2016

Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial

Paolo A. Ascierto, Vito Vanella, Antonio Maria Grimaldi, Festino Lucia, Marco Palla, Ester Simeone, Nicola Mozzillo

10.09.2016 | Original Article | Ausgabe 11/2016

Regulatory T cells function at the early stage of tumor progression in a mouse model of tongue squamous cell carcinoma

Kentaro Miki, Yorihisa Orita, Yuka Gion, Soshi Takao, Kyotaro Ohno, Mai Takeuchi, Toshihiro Ito, Hiroyuki Hanakawa, Tomoyasu Tachibana, Hidenori Marunaka, Takuma Makino, Akira Minoura, Akihiro Matsukawa, Kazunori Nishizaki, Tadashi Yoshino, Yasuharu Sato

10.09.2016 | Original Article | Ausgabe 11/2016

Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma

Irina V. Tiper, Tonya J. Webb

12.09.2016 | Meeting Report | Ausgabe 11/2016

“Cancer Bio-Immunotherapy in Siena”: Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8–10, 2015

Michele Maio, Erica Bertocci, Carolina Fazio, Carla Chiarucci, Ornella Cutaia, Elisa Scala, Gianluca Giacobini, Maria Fortunata Lofiego, Ester Fonsatti, Cristina Maccalli, Hugues J. M. G. Nicolay, Giorgio Parmiani, NIBIT

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise